These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 30542731)
1. Upregulation of thyroid hormone receptor interactor 13 is associated with human hepatocellular carcinoma. Ju L; Li X; Shao J; Lu R; Wang Y; Bian Z Oncol Rep; 2018 Dec; 40(6):3794-3802. PubMed ID: 30542731 [TBL] [Abstract][Full Text] [Related]
2. Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4. Zhu MX; Wei CY; Zhang PF; Gao DM; Chen J; Zhao Y; Dong SS; Liu BB J Exp Clin Cancer Res; 2019 Sep; 38(1):409. PubMed ID: 31533816 [TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone receptor interactor 13 (TRIP13) overexpression associated with tumor progression and poor prognosis in lung adenocarcinoma. Li W; Zhang G; Li X; Wang X; Li Q; Hong L; Shen Y; Zhao C; Gong X; Chen Y; Zhou J Biochem Biophys Res Commun; 2018 May; 499(3):416-424. PubMed ID: 29567476 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway. Lu R; Zhou Q; Ju L; Chen L; Wang F; Shao J Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184074 [TBL] [Abstract][Full Text] [Related]
5. Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4. Ye C; Zhang X; Chen X; Cao Q; Zhang X; Zhou Y; Li W; Hong L; Xie H; Liu X; Cao H; Wang YJ; Kang B Cell Oncol (Dordr); 2020 Apr; 43(2):279-295. PubMed ID: 31848930 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma. Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401 [TBL] [Abstract][Full Text] [Related]
7. Thyroid Receptor-Interacting Protein 13 is Correlated with Progression and Poor Prognosis in Bladder Cancer. Niu L; Gao Z; Cui Y; Yang X; Li H Med Sci Monit; 2019 Sep; 25():6660-6668. PubMed ID: 31486418 [TBL] [Abstract][Full Text] [Related]
8. Upregulated long non-coding RNA LOC90784 promotes cell proliferation and invasion and is associated with poor clinical features in HCC. Xu JH; Chang WH; Fu HW; Shu WQ; Yuan T; Chen P Biochem Biophys Res Commun; 2017 Aug; 490(3):920-926. PubMed ID: 28651931 [TBL] [Abstract][Full Text] [Related]
9. TRIP13 interference inhibits the proliferation and metastasis of thyroid cancer cells through regulating TTC5/p53 pathway and epithelial-mesenchymal transition related genes expression. Yu L; Xiao Y; Zhou X; Wang J; Chen S; Peng T; Zhu X Biomed Pharmacother; 2019 Dec; 120():109508. PubMed ID: 31648166 [TBL] [Abstract][Full Text] [Related]
10. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma. Tian F; Cai D Gene; 2022 Jan; 807():145964. PubMed ID: 34530087 [TBL] [Abstract][Full Text] [Related]
11. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis. Luo Y; Lin J; Zhang Y; Dai G; Li A; Liu X Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636 [TBL] [Abstract][Full Text] [Related]
12. TRIP13 is a predictor for poor prognosis and regulates cell proliferation, migration and invasion in prostate cancer. Dong L; Ding H; Li Y; Xue D; Li Z; Liu Y; Zhang T; Zhou J; Wang P Int J Biol Macromol; 2019 Jan; 121():200-206. PubMed ID: 30267820 [TBL] [Abstract][Full Text] [Related]
13. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma. Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway. Gao Y; Liu S; Guo Q; Zhang S; Zhao Y; Wang H; Li T; Gong Y; Wang Y; Zhang T; Dong Z; Bacich D; Chowdhury WH; Rodriguez R; Wang Z Int J Biol Sci; 2019; 15(7):1488-1499. PubMed ID: 31337978 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263 [TBL] [Abstract][Full Text] [Related]
16. Loss of thyroid hormone receptor interactor 13 inhibits cell proliferation and survival in human chronic lymphocytic leukemia. Zhou K; Zhang W; Zhang Q; Gui R; Zhao H; Chai X; Li Y; Wei X; Song Y Oncotarget; 2017 Apr; 8(15):25469-25481. PubMed ID: 28424416 [TBL] [Abstract][Full Text] [Related]
17. TRIP13 promotes proliferation and invasion of epithelial ovarian cancer cells through Notch signaling pathway. Zhou XY; Shu XM Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):522-529. PubMed ID: 30720159 [TBL] [Abstract][Full Text] [Related]
18. TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis. Zhang G; Zhu Q; Fu G; Hou J; Hu X; Cao J; Peng W; Wang X; Chen F; Cui H Br J Cancer; 2019 Dec; 121(12):1069-1078. PubMed ID: 31740732 [TBL] [Abstract][Full Text] [Related]
19. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma. Zhou J; Li W; Guo J; Li G; Chen F; Zhou J Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]